Hosted on MSN29d
Semaglutide can also be beneficial to people with type 1 diabetes, clinical trial findsMore information: Melissa-Rosina Pasqua et al, Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial, Nature Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback